Open AccessRationale and Design for a Multicenter, Phase II Study of Durvalumab Plus Concurrent Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer: The DOLPHIN Study (WJOG11619L)
Author(s) -
Motoko Tachihara,
Kayoko Tsujino,
Takeshi Ishihara,
Hidetoshi Hayashi,
Yuki Sato,
Takeshi Kurata,
Shunichi Sugawara,
Isamu Okamoto,
Shunsuke Teraoka,
Koichi Azuma,
Haruko Daga,
Masafumi Yamaguchi,
Takeshi Kodaira,
Miyako Satouchi,
Mototsugu Shimokawa,
Nobuyuki Yamamoto,
Kazuhiko Nakagawa
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s336262
Subject(s) - durvalumab , medicine , oncology , lung cancer , radiation therapy , clinical endpoint , chemoradiotherapy , chemotherapy , immunotherapy , cancer , response evaluation criteria in solid tumors , phases of clinical research , clinical trial , nivolumab